Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83'000 women with breast cancer from 16 countries by Beral, Valerie et al.
  
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but dos not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as:  
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Multilayered genetic and omics dissection of mitochondrial 
activity in a mouse reference population. 
Authors: Wu Y, Williams EG, Dubuis S, Mottis A, Jovaisaite V, Houten 
SM, Argmann CA, Faridi P, Wolski W, Kutalik Z, Zamboni N, Auwerx J, 
Aebersold R 
Journal: Cell 






Multilayered Genetic and Omics Dissection of Mitochondrial
Activity in a Mouse Reference Population
Yibo Wu1,9, Evan G. Williams2,9, Sébastien Dubuis1, Adrienne Mottis2, Virginija Jovaisaite2,
Sander M. Houten3, Carmen A. Argmann4, Pouya Faridi1,5, Witold Wolski1, Zoltán
Kutalik6,7, Nicola Zamboni1, Johan Auwerx2,*, and Ruedi Aebersold1,8,*
1Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische
Hochschule Zürich (ETHZ), Zurich 8093, Switzerland 2Laboratory of Integrative and Systems
Physiology, Interfaculty Institute of Bioengineering, École Polytechnique Fédérale de Lausanne
(EPFL), Lausanne 1015, Switzerland 3Department of Clinical Chemistry, Laboratory Genetic
Metabolic Diseases and Department of Pediatrics, Academic Medical Center, University of
Amsterdam, 1105 AZ Amsterdam, the Netherlands 4Department of Medical Biochemistry,
Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands
5Department of Traditional Pharmacy, School of Pharmacy and Pharmaceutical Sciences, Shiraz
University of Medical Sciences, Shiraz 71349-14693, Iran 6Institute of Social and Preventive
Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne 1010,
Switzerland 7Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland 8Faculty of Science,
University of Zurich, Zurich 8057, Switzerland
SUMMARY
The manner by which genotype and environment affect complex phenotypes is one of the
fundamental questions in biology. In this study, we quantified the transcriptome—a subset of the
metabolome—and, using targeted proteomics, quantified a subset of the liver proteome from 40
strains of the BXD mouse genetic reference population on two diverse diets. We discovered
dozens of transcript, protein, and metabolite QTLs, several of which linked to metabolic
phenotypes. Most prominently, Dhtkd1 was identified as a primary regulator of 2-aminoadipate,
explaining variance in fasted glucose and diabetes status in both mice and humans. These
integrated molecular profiles also allowed further characterization of complex pathways,
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particularly the mitochondrial unfolded protein response (UPRmt). UPRmt shows strikingly variant
responses at the transcript and protein level that are remarkably conserved among C. elegans,
mice, and humans. Overall, these examples demonstrate the value of an integrated multilayered
omics approach to characterize complex metabolic phenotypes.
INTRODUCTION
The central dogma of molecular biology states that genetic information encoded in DNA is
first transcribed by RNA polymerase, then translated by ribosomes into proteins. However,
the DNA sequence of a gene provides little information for predicting when, where, and to
what extent its associated RNA and protein products will be expressed. Since the advent of
microarray technology, comprehensive gene expression patterns—i.e., the transcriptome—
can be precisely and comprehensively quantified across large populations. Unfortunately,
transcript levels generally have only modest correlation with the levels of corresponding
proteins (Ghazalpour et al., 2011; Gygi et al., 1999; Schwan-häusser et al., 2011), and
genetic variants similarly affecting both the transcript and peptide levels of a gene are
relatively uncommon (Albert et al., 2014; Skelly et al., 2013). As proteins in most cases are
more directly responsible than transcripts in the regulation of cellular pathways—and
ultimately phenotypic traits—there is a critical need for efficient, large-scale, and accurately
quantitative proteomics methods to complement transcriptomic data sets.
Over the past decade, the development of discovery mass spectrometry (“shotgun”) has
allowed the first large-scale studies on quantitative proteomics. In this approach, protein
extracts are cleaved into short peptide sequences, which are then chromatographically
separated and analyzed by tandem mass spectrometry. This allows the untargeted discovery
of thousands of peptides, but if the number of unique peptide fragments in a sample
significantly exceeds the number of available sequencing cycles (as in whole proteome
extracts), any individual peptide will be inconsistently sampled across repeat analyses. This
reduces the technical reproducibility but moreover means that the number of peptides
consistently quantified across all (or most) samples decreases as the study size increases
(Karpievitch et al., 2012). Consequently, discovery mass spectrometry strategy has yielded
mixed results in large population studies (Ghazalpour et al., 2011; Holdt et al., 2013),
particularly as specific peptides of interest cannot be targeted, and the most consistently
identified peptides are biased toward those of higher abundance (Callister et al., 2006). To
overcome these hurdles, selected reaction monitoring (SRM) was developed, which perfects
technical reproducibility and allows consistent multiplexed quantitation of target proteins by
deploying a mass spectrometric measurement assay that is specific for each targeted peptide
(Lange et al., 2008a). Thus, hundreds of target peptides can be consistently and accurately
quantified across large populations of samples. Recent studies in yeast have shown that the
proteins and transcripts of genes are typically controlled by different, distinct mechanisms
(Albert et al., 2014; Picotti et al., 2013). However, these hypotheses have not been well
tested in mammalian genetic reference populations (GRPs) through multilayered
transcriptomic and proteomic strategies.
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Large GRPs are frequently used to determine to which extent phenotypic variation is driven
by genetic variants (i.e., heritability), and to subsequently identify genes driving such
variation. These genes can be identified by genome-wide association studies (GWASs) or by
quantitative trait locus (QTL) mapping, approaches that have been applied to various species
and have led to the successful identification of dozens of major allelic variants (Andreux et
al., 2012; De Luca et al., 2003; Deeb et al., 1998; Yvert et al., 2003). In mammals, the
murine BXD family is the largest and most well-studied GRP, consisting of ~150
recombinant inbred strains descended from C57BL/6J (B6) and DBA/2J (D2) (Andreux et
al., 2012). Using 40 strains of this population on both chow (CD) and high fat (HFD) diets,
we have obtained major metabolic phenotypes and established a multilayered data set
focused on 192 metabolic genes expressed in the liver. For all genes, we know the sequence
variants, transcript levels, and protein levels in all cohorts. These data are further
supplemented with targeted metabolite analysis in the liver and serum, generating the first
large-scale multilayered quantitative picture of any cellular process in the BXD population.
RESULTS
Protein Targeting across a Genetically and Environmentally Diverse Murine Population
We first selected 192 metabolic proteins for study, with particular focus on genes regulating
mitochondria and general energy metabolism. For each gene, synthetic peptides were
generated based on established assays (Picotti et al., 2010) (Figure 1A) to accurately
quantify each protein across all cohorts. To validate peptide measurements, we compared
the coefficients of variation (CV) among technical and biological peptide replicates. Both
technical and biological replicates showed a high degree of reproducibility (CV ~ 0.09 and
0.12, respectively), indicating the quantification of targeted peptides is sufficiently accurate
across large, diverse populations. More importantly, the results for biological replicates
reveal nearly equally high overall reproducibility (r > 0.98; Figure 1B), suggesting low
biological variance within each cohort, particularly relative to cross-cohort variance (CV ~
0.33); 82.1% of the quantified peptides are highly variable (CV > 0.20), indicating that the
biological error (i.e., variation within a cohort) is much smaller than the variation induced by
differences in genotypes and diet. We observed nearly complete quantification of all 192
proteins across all cohorts, with only ~60 missing peptide counts out of ~15,000
measurements (i.e., 99.6% completion; Figure 1C, top). This completion is similar to the
level of completeness achieved by microarrays (Figure 1C, bottom) and is a major contrast
to shotgun-acquired proteomics, which typically have completeness of ~70% (Karpievitch et
al., 2012).
It has been well established that transcriptomic networks of many metabolic processes
covary quite well, e.g., within the electron transport chain or within the citric acid cycle
(Ihmels et al., 2002). At the protein level, proteins that function in common biological
processes or that localize to the same functional modules are also reported to be subject to a
similar regulatory process and generally covary (Foster et al., 2006). To validate and
identify which of these 192 proteins vary synchronously, we computed the robust Spearman
correlation network for all protein pairs using the full SRM data set (Figure 1D). The
resulting network contained 82 correlated nodes (proteins) with 211 edges in 3 main
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enrichment clusters. As expected, proteins within ontologies are highly correlated such as
for mitochondria (Figure 1Da) and lipid metabolism (Figure 1Db). Within Figure 1Da are
five of the six measured proteins involved in mitochondrial unfolded protein response
(UPRmt) (HSPD1, HSPE1, HSPA9, CLPP, and LONP1, indicated in red), along with three
of the four measured NADH dehydrogenase genes (NDUFA1, NDUFB3 and NDUFS6, in
blue) and four of the eight measured mitochondrial-encoded proteins (MT-CYB, MT-CO2,
MT-CO3, and MT-ND3, in black). Meanwhile, proteins involved in carbohydrate
metabolism are enriched in the same cluster (Figure 1Dc). These results show that
functionally related proteins tend to be coordinately regulated at a protein level and that
coregulation of protein abundance is strongly maintained for certain processes. To validate
the biological significance of these function-based covariation clusters, we further
investigated one: the UPRmt network (elaborated on later).
Protein and mRNA Gene Products Generally Do Not Correlate
With the general protein measurements validated, we generated a global overview of how
genotype and diet influence differential transcript and protein expression (Figure 2A;
numerical values listed in Table S1 available online). At the genetic level, transcripts and
proteins map to an equivalent number of significant QTLs: we detected 65 significant
transcript QTLs (eQTLs—blue lines at the center) and 57 significant protein QTLs (pQTLs
—red lines at the center). However, though the total number of eQTLs and pQTLs are
roughly equivalent, the predominant type of regulation was very different: 74% of the
eQTLs are cis-mapping (ratio of solid to dashed blue lines), versus only 31% of pQTLs
(ratio of solid to dashed red lines). This indicates a closer connection between a transcript
and its gene than a protein and its gene. In general, trans-mapping proteins and transcripts
mapped evenly across the genome, not yielding any clear “hot spots” for these metabolic
genes (sample magnification of QTLs mapping to chromosome 5 is shown in Figure 2B).
Within each diet, we found proteins and transcripts to be nominally correlated for ~25% of
genes (i.e., Spearman correlation p value < 0.05; Figure 2C, diets considered separately),
similar to findings in other species and populations (Foss et al., 2007; Ghazalpour et al.,
2011; Schwanhäusser et al., 2011; Skelly et al., 2013). Of the correlated transcript-peptide
pairs (46 in CD, 55 in HFD), 31 correlate significantly in both cohorts, whereas 70 pairs
correlate in only one dietary cohort. Correspondingly, while ~50% of genes were affected by
diet, transcripts were more frequently influenced (84 of 189) than proteins (37 of 192), with
only 21 genes affected at both the transcript and protein levels (Figure 2D). Genes that were
the most strongly affected by diet at the transcript level (Figure 2E) tend to be similarly
affected at the protein level (Figure 2F)—e.g., Cyp3a11 is higher in CD—though exceptions
are frequent, e.g., Srebf1 mRNA is induced by HFD, but unaffected at the protein level,
while in another counterexample, the HFD cohorts have more ETFDH protein, but less of
the transcript. Thus, while transcripts and proteins are moderately covarying estimations of
their gene’s activity and typically have covarying responses to external factors (e.g., diet),
these trends are too weak to support the measurement of any one particular transcript to
serve as a proxy for the protein (or vice versa) without prior knowledge.
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Most Transcript and Protein QTLs Do Not Overlap
Of the 192 target genes, 79 map to a significant eQTL or pQTL in at least one dietary
condition. A strong majority of significantly mapped QTLs, ~80%, are unique to either the
transcript level or protein level (Figure 3A). At the transcript level, 28 genes map to cis-
eQTLs, 20 of which are in both diets, while 17 transcripts map as trans-eQTLs, none of
which are observed in both diets. Together, we observed 65 significant eQTLs stemming
from 45 distinct genes (Figure 3B, left; the 20 distinct genes that map cis in both diets
contribute 40 significant eQTLs). The range of transcript variance within a diet was a strong
predictive factor for observing an eQTL. Transcripts in the least variable quartile (range <
1.5-fold from the lowest to the highest expressing BXD strain) contained only 10% of the
significant QTLs. In contrast, the second quartile (range 1.5- to 1.65-fold) contained 17%,
the third quartile (range 1.65- to 2.0-fold) contained 29%, and the top quartile (range ≥ 2.0-
fold) contained 41% of the significant QTLs.
At the protein level, 57 significant pQTLs stem from 48 distinct proteins (Figure 3B, right).
In striking contrast to transcript regulation, only 13 distinct proteins map to cis-pQTLs, five
in both diets, while 36 proteins map as trans-pQTLs. No trans-pQTLs are consistent across
diets, although three proteins significantly map to separate trans-pQTLs in both diets (Cd44,
Acss2, and Ndufs6), and one (Hmgcs1) maps to both cis- and trans-pQTLs. Together with
transcript data, we could moderately predict pQTLs: of the 28 genes with cis-eQTLs, 12
correlated well (r > 0.40) between the transcript and protein. Of these 12 genes, five
(Dhtkd1, Nnt, Tymp, Gclm, and Bckdhb) map significantly as pQTLs and eQTLs in both
diets (Figures 3C, 3D, S2A, and S2B; Bckdhb in Figure 4B), and four (Acox1, Mfn1, Mri1,
and Pm20d1) map as pQTLs and eQTLs in at least one diet. Interestingly, three proteins
mapped as cis-pQTLs and correlated with their transcript, but did not have associated
eQTLs (Hmgcs1, Car3, and Acsf2), suggesting the genetic variant driving these changes
manifests more prominently at the protein level than at the transcript level (e.g., Figure 3E).
Diet also plays a clear role in the consistent identification of cis-QTLs. For the 20 genes
with cis-eQTLs identified in both diets, HFD significantly affects the levels of only one
(Pmpcb; Figure 3F). Conversely, for the eight genes mapping to an eQTL in only one diet,
the levels of only three are affected (Ndufs2, Acads, and Aldh4a1). Similar trends are
observed at the protein level: of the five cis-pQTLs found in both diets, none are affected by
diet, while for the eight genes with cis-pQTLs in only one diet, only the levels of one
(Hmgcs1) are affected. This relationship is similar for trans-eQTLs: of the 17 genes with
trans-eQTLs, only four are influenced by diet (whereas ~50% of total transcripts are
influenced by diet). However, diet does not appear to strongly influence trans-pQTLs, where
11 of the 39 are affected by diet, a similar proportion to the overall effect, recalling that
~20% of proteins have levels influenced by diet (Figure 2D). Together this suggests diet can
change the genetic factors regulating these genes without changing their overall levels.
While high expression variability is associated with stronger QTLs, it is not a definitive
predictor, e.g., Mup3 is highly variable, strongly affected by diet, and consistently expressed
between mRNA and protein, but does not map to a QTL in any measurement (Figure 3G).
Therefore, while the ability to predict peptide levels based on transcript measurements on a
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systems scale is quite powerful (the ~25% to ~37% of correlated transcript-peptide pairs is
much better than the ~5% expected by chance), the probability to fail of any one particular
gene is quite high. These chances can be adjusted somewhat—perturbations dramatically
affecting transcript levels are more likely to manifest at the protein level and vice versa—but
even so, prior research must be established before gene expression can be confidently
considered a proxy for protein levels in targeted genetic studies. This also indicates that
applying quantitative proteomic data to pathways established at the transcript level can
indicate new links that were previously obscured.
Functional Relationships of pQTLs to Phenotypes
To characterize the cellular function and potential physiological relevance of the pQTLs, we
first collated all Entrez (Maglott et al., 2005) and UniProt (Magrane and Consortium, 2011)
entries for genes with the most significant pQTLs (LRS ≥ 20) (Table 1). As the BXDs have
extensive historical phenotype and metabolite data available on GeneNetwork (Wang et al.,
2003), we performed a phenome-wide association study to determine if any collected
phenotype data mapped at least suggestively (likelihood ratio statistic [LRS] ≥ 12) as
clinical QTLs (cQTL) to the same loci. A handful of phenotypic connections in the BXDs
were supported by literature, including a link between Nnt and insulin (Wong et al., 2013)
and between Car3 and subcutaneous adipose mass (Mitterberger et al., 2012). However, for
the majority of pQTLs, no established cQTLs mapped to the same loci. We thus selected the
two genes with the most significant and novel pQTLs in both diets for follow-up analysis
and validation— Bckdhb and Dhtkd1.
Bckdhb is a subunit of the branched chain amino α-keto acid dehydrogenase (BCKD, EC
2.7.11.4) complex (Figure 4A) and maps to two of the most significant eQTLs and among
the most significant consistent pQTLs (Figure 4B; Tables 1 and S1). Bckdhb transcript and
protein levels are highly variable across strains and are unaffected by diet (Figure 4B), but
no cQTL mapped to this locus. In humans, variant alleles of BCKDHB are known to cause
Type IB maple syrup urinary disease (MSUD), an inborn error of metabolism characterized
by a buildup of branched chain amino acids (BCAAs) and branched chain α-keto acids
(BCKAs). MSUD manifests in newborns and is associated with neurological problems and
delayed development, and if untreated it can be fatal (Chuang and Shih, 2001). This pathway
is a multi-tissue system driven particularly by the muscle and liver, and consequently it is
diagnosed by significant increases of BCAAs and BCKAs in both the serum and urine, a
decrease in alanine, and/or by detection of L-alloisoleucine (Chuang and Shih, 2001;
Haymond et al., 1978). Genetically engineered mouse models of MSUD have similar
phenotypic progression as humans, including the same metabolite buildups and related
phenotypes such as movement difficulties and reduced body growth (Koepp et al., 1974; Wu
et al., 2004). We thus examined the BXDs with respect to these traits. While L-
alloisoleucine was not detected, strains with the less functional B6 allele of Bckdhb had a
marked increase in the BCAA/alanine ratio in the serum and liver (Figure 4C, left and right,
respectively). However, no association with movement, growth or body weight was present
in the BXDs (data not shown), suggesting that this Bckdhb variant carries only the
subclinical metabolic effects of MSUD. This observation is also in line with the human
disease, where MSUD symptoms are only apparent when BCKD activity is < ~30% of
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normal (Skvorak, 2009). In contrast, strains with the B6 allele of Bckdhb have ~50% the
enzymatic activity compared to those with the D2 allele. However, this raises the possibility
that a sustained BCAA loading test in the BXDs may lead to clinical manifestation of the
intermittent form of MSUD.
To continue scanning for physiological links with the proteins examined, we also
investigated the strongest pQTL in both diets. This gene, Dhtkd1, encodes a mitochondrial
protein operating as the E1 subunit of a dehydrogenase complex involved in lysine
metabolism (EC 1.2.4.2; Figure 4D). In humans, variants in DHTKD1 have been linked to
urinary buildup of 2-aminoadipate (2-AA) and 2-oxoadipate, yet the few studies on the
physiological consequences of these variants are conflicted (Danhauser et al., 2012; Houten
et al., 2013; Xu et al., 2012). After measuring the metabolites involved in this pathway in the
BXD liver and serum, we observed a striking correlation between DHTKD1 levels and 2-
AA (Figure 4E, left) as well as between metabolites in the pathway itself (Figure 4E, right
and Figure S2A). Moreover, 2-AA mapped significantly in both diets as an mQTL to the
locus of Dhtkd1 itself, indicating the BXDs share an inborn error of metabolism similar to
humans (Figure 4F). Due to the strength and consistency of this correlation across diets, we
hypothesized this variant may lead to phenotypic consequences and inform for human
validation.
DHTKD1: A Regulator of Glucose Homeostasis
Inhibition of DHTKD1 in human liver cells is known to diminish mitochondrial activity (Xu
et al., 2013), and external administration of 2-AA improves insulin secretion in mice (Wang
et al., 2013). We thus examined whether the natural genetic variants in Dhtkd1 may also
influence glucose homeostasis in the BXDs. The BXDs have varying responses to HFD-
induced diabesity and include some resistant strains, but most strains are affected, leading to
general increases in liver weight, serum cholesterol, glucose, and overall body weight
(Figures 5A and S2B). Strikingly, 2-AA is negatively associated with liver mass and fasted
glucose levels in both diets, and with serum cholesterol and insulin in CD (Figure 5B). Other
metabolites in this pathway were also connected to the same phenotypes and with negative
correlation [e.g., saccharopine (Figure 5C) and α-ketoglutarate (Figure S2C)]. Interestingly,
2-AA levels are significantly decreased in the HFD cohorts (Figure 5D), despite the genetic
regulation of 2-AA by Dhtkd1 being equivalent between CD and HFD cohorts (Figures 4E
and 4F). However, this decrease is not directly linked to diet, but instead with the animals’
progression toward diabetes. Based on HOMA insulin resistance indices (Lee et al., 2008),
most HFD-fed BXD animals (108 of 180) became glucose intolerant and insulin resistant
over the six-month period of the dietary challenge (Figure S2D). Conversely, only 18% of
CD animals (29 of 165) have poor insulin sensitivity. Strikingly, the changes in 2-AA levels
go in tandem with the HOMA index: animals with worse insulin sensitivity have lower 2-
AA, and animals with good insulin sensitivity have equivalent levels of 2-AA, with no
effects linked directly to diet (Figure 5E). With this in mind, we further examined 2-AA in
two independent population studies. In the Hybrid Mouse Diversity Panel, a recent profile of
liver metabolomes in 96 cohorts in the fasted state contained 2-AA measurements
(Ghazalpour et al., 2014). In this diverse population, which includes~30 BXD strains (with
only one strain overlapping with those in our study), 2-AA is diminished in cohorts with
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higher fasted glucose (Figure 5F), and the two are again negatively correlated (Figure S2E).
Likewise, we observed the same trend in a human population study (Cohorte Lausannoise
[CoLaus] study [Firmann et al., 2008]), in which we recently analyzed the spot urine
samples of 835 middle-aged or elderly individuals (Rueedi et al., 2014). In this cohort,
diabetic patients (Figure S2E) also displayed a marked decrease in 2-AA levels (Figure 5F).
Together, these findings indicate that Dhtkd1 plays a major role in the regulation of 2-AA in
both mice and humans and that the modulation of this pathway may influence the
development of diabetes.
The Mitochondrial Unfolded Protein Response
The UPRmt is a mitochondrial stress response pathway that is activated by proteostatic
stress, such as by accumulation of unassembled or unfolded proteins in the mitochondria
(Zhao et al., 2002), by the presence of an imbalance between mitochondrial and nuclear
encoded proteins (Houtkooper et al., 2013), or by electron transport chain defects (Durieux
et al., 2011; Runkel et al., 2013). The activation of UPRmt in turn leads to the transcription
and translation of nuclear-encoded protective genes such as mitochondrial chaperones and
proteases to reestablish mitochondrial proteostasis (reviewed in Haynes et al., 2013;
Jovaisaite et al., 2014; Wolff et al., 2014). The bulk of research on UPRmt has taken place
using C. elegans and mammalian cell lines, thus little is known about when or how UPRmt
occurs in vivo in mammals. Furthermore, as the UPRmt is a stress response tied to
maintaining mitochondrial protein balance, we hypothesized that its protein correlation
networks may be different than those generally examined at the transcriptional level.
In the worm, two “classical” approaches have been typically used to induce UPRmt: the loss
of function of cco-1, a nuclear encoded component of the electron transport chain (Durieux
et al., 2011), or the loss of function of spg-7, a mitochondrial protein quality-control
protease (Yoneda et al., 2004). We confirmed that the knockdown of either gene by RNAi
triggers the UPRmt response in C. elegans, by strong induction of the mitochondrial
chaperone hsp-6 and of the proteases lonp-1 and clpp-1 (Figure 6A). Moreover, we linked
this UPRmt activation to specific phenotypes—a major reduction in size and mobility, as
well as a decrease in oxygen consumption—which are consequences of mitochondrial stress
(Figure 6B). However, it has not been previously shown whether this coordinated regulation
of UPRmt genes is conserved in mammals in vivo.
In the BXDs, we investigated the expression of six members of the UPRmt pathway, which
are well conserved from C. elegans: mitochondrial chaperones (Hspd1, Hspe1, Hspa9),
proteases (Clpp, Lonp1), and a transcriptional regulator involved in UPRmt (Ubl5). These
UPRmt genes are also coordinately regulated at both mRNA and protein level in the BXDs,
but with much stronger connections among proteins (Figure 6C). Moreover, the UPRmt
network correlates negatively with Cox5b and Spg7 (mouse orthologs of worm cco-1 and
spg-7, respectively), indicating that low abundance of these genes amplifies UPRmt in
mammals as in C. elegans (Figure 6D). The network is also influenced in part by diet. While
Cox5b expression patterns are similar between CD and HFD, Spg7 covariation is disjointed
between the dietary cohorts (Figure 6E). This may explain why, despite a similar overall
UPRmt response in both diets (Figures 6D and 6F), Spg7 trends positively in HFD cohorts,
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while Cox5b remains consistent (Figure 6G). Using four large transcriptional studies of
human tissue biopsies, we observe similar transcriptional links, particularly including a
strong network between all the UPRmt genes (Figure 6H). In humans, SPG7 is a consistent
negative correlate of this network, in contrast to COX5B, which generally has positive
covariation with the UPRmt response (Figure 6I). Thus, while many of the overall regulators
of UPRmt remain coregulated across species—worm, mouse, and human—particular
nuances of its activation pathways appear to be variable dependent on species, environment,
tissue, and likely other factors.
DISCUSSION
Due to major differences in transcript and protein regulation, it has become increasingly
clear that systems proteomics is essential for the analysis of complex systems such as
metabolism (Khan et al., 2013; Skelly et al., 2013). Traditionally this was attempted by
semiquantitative immunoassays such as ELISA or western blotting, yet these techniques
allow only a handful of proteins to be measured in parallel and are moreover limited by the
scarcity of quantitative immunoassays and the dubious quality of many antibodies (Marx,
2013). Recent shotgun proteomics experiments on diverse populations have provided
fundamental data on protein variance in populations of yeast (Albert et al., 2014; Skelly et
al., 2013), mammals (Ghazalpour et al., 2011), and humans (Hwang et al., 2010). However,
the inability to measure target proteins has limited the application of this approach in the
study of disease pathways. New developments in mass spectrometry have led to SRM, a
targeted quantitative systems proteomics technique in which choice proteins can be
quantified based on a priori information. This technique has been recently applied in a
moderate-sized yeast population study (Picotti et al., 2010), but until now it has not been
applied to study genetic regulation in multicellular species or for a choice pathway.
In this study, we quantified 192 metabolism genes at the transcript and protein levels in
livers from 77 cohorts of the BXD GRP under two different dietary conditions. Along with
sequence variants, basic metabolomics, and phenotype data, this combined multilayered
population data set enabled us to accurately estimate abundance changes in gene products
due to genotype, diet, and gene-by-environment interactions (GXE). By complementing
these layers, we were able to tentatively link dozens of pQTLs with phenotypes. Of the ~50
of significant pQTLs identified, we established links between four genes leading to
phenotypic consequence: two novel and two confirmatory. For these genes, Nnt, Car3,
Dhtkd1, and Bckdhb, coding differences between B6 and D2 alleles were linked to robust
differences at both the transcript level and protein level, leading to shared cis-regulatory
eQTLs and pQTLs and then to phenotypic consequences. While Nnt has been previously
attributed as causal to differences in insulin secretion in the BXDs (Wong et al., 2013), the
other pQTLs are novel, including Car3, which was previously linked to adiposity only in
knockout mice (Mitterberger et al., 2012). For Bckdhb, strains carrying the B6 allele have a
~50% reduction in enzyme levels, which leads to a buildup of BCAA levels and a decrease
in alanine levels, as in the intermittent form of MSUD. In humans, MSUD is a rare inborn
error of metabolism, and while BXDs do not suffer any overt physiological consequences of
BCKDHB deficiency in the basal state, certain dietary stresses may magnify the symptoms
and make the BXDs appropriate to model MSUD.
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For Dhtkd1, the BXD strains map to highly significant and overlapping eQTLs and pQTLs
with an approximately bimodal distribution with 2-fold variance between strains with the B6
(low) or the D2 allele (high) of the gene and with no effect from diet. Furthermore, the
metabolite 2-AA maps as a significant mQTL to the Dhtkd1 locus in both diets, despite a
marked decrease of 2-AA levels in HFD cohorts. Interestingly the decrease in 2-AA is not
directly due to the HFD, but rather it is due to the increased penetrance of insulin resistance
after HFD. Moreover, prior works show that external administration of 2-AA can improve
insulin sensitivity and glucose response in mice (Wang et al., 2013), indicating that variants
in Dhtkd1 and 2-AA levels may be driving the pathogenesis of diabetes, rather than being
mere passive biomarkers of the disease. Strikingly, we replicated this association between 2-
AA and high glucose levels in a recent and completely independent metabolomic data set
collected in the Hybrid Mouse Diversity Panel (Ghazalpour et al., 2014). Furthermore, and
clinically relevant, we demonstrated in a human population-based sample, Co-Laus, that
diabetic patients likewise have lower urinary levels of 2-AA (Rueedi et al., 2014). Thus, 2-
AA levels are consistently linked to the diabetes status in both mice and humans, and in the
BXDs we can unequivocally attribute a causal part of this variance to variants in Dhtkd1.
The BXD strains were necessary to bring the hypothesis to power a human study and also
confirm that the mouse link has relevance for human disease. Together, these findings
further validate the BXD mouse population as a model for human metabolic diseases
(Andreux et al., 2012), and they indicate a critical need for multilayered measurements to
effectively analyze complex systems, particularly within the context of the study of GXE.
It is worth stressing that novel regulatory mechanisms can be found either through QTL
analysis and their equivalent from GWAS, SNP analysis, or through network analyses,
which are a complementary and powerful approach to dissect complex traits. The network
approach is particularly viable when backed by high-depth multilayered data sets such as
illustrated by our example of UPRmt. UPRmt is a reparative pathway activated by
mitochondrial proteotoxic stress that has been primarily studied in the C. elegans and in
cultured cells, but little is known about whether it occurs in vivo in mammals. We examined
six genes that are known to be major regulators of C. elegans UPRmt and that are conserved
in mammals. These six genes form a robust coexpression network in both diets at the
transcriptional and proteomic levels, with the proteomic connections being stronger,
befitting the role of UPRmt as a sensor and regulator of protein stress. One observation that
stood out in the analysis of the UPRmt was the striking “contradiction” between the Ubl5
transcript and UBL5 protein correlations to the UPRmt network. Ubl5 is a transcriptional
regulator known to induce UPRmt; yet, in both worms and mice, its transcript levels
decrease when UPRmt is activated. Conversely, the UBL5 protein is increased with UPRmt
activation in the BXDs, an observation also previously reported in C. elegans (Benedetti et
al., 2006). This discordance in protein and transcript regulation suggests the existence of
posttranscriptional mechanisms or a negative feedback loop, which could not be detected at
the transcript or protein level alone. While there remains a great deal of this pathway left to
be explored, it is clear that accurate, systems-scale protein measurements are essential to
effectively model complex protein response networks like UPRmt.
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Today, there is an unprecedented capacity for accurate measurement quantification of nearly
all aspects of biology. Surprisingly, perhaps, proteins remain one of the most difficult
aspects of biology to precisely measure on a systems scale, though it has been long clear that
transcripts only serve as a weak proxy for protein levels (Gygi et al., 1999). Our data show
that the integration of systems proteomics data sets with different layered systems
measurements provides unprecedented insights into the mechanistic regulation of complex
systems, such as exemplified by metabolism, which can eventually lead to the improved
diagnosis and treatment of metabolic disease.
EXPERIMENTAL PROCEDURES
Animals
Forty strains of the BXD population—40 on CD, 37 on HFD—with ~10 male animals from
each strain were separated into 2 cohorts of 5 for each diet. Food access was ad libitum for
CD—Harlan 2018 (6% kCal/fat, 74% carbohydrate, 20% protein)—and for HFD (Harlan
06414 [60% kCal/fat, 20% carbohydrate, 20% protein]). HFD cohorts received the diet from
week 8 until sacrifice. Each cohort was communally housed until week 23, after which
animals were single caged until tissues collection at 29 weeks after an overnight fast.
Tissues were collected from 183 CD and 168 HFD animals, with at least 3 biological
replicates for all cohorts. All research was approved by the Swiss cantonal veterinary
authorities of Vaud under licenses 2257.0 and 2257.1.
Sample Preparation and Analysis
For liver analyses, three ~100 mg pieces were taken from cold storage for each individual
and then weighed and sorted for mRNA, protein, and metabolite measurements. For
microarray, mRNA from three to five individuals per cohort were prepared separately and
then pooled equally after nanodrop quantification and run on the Affymetrix Mouse Gene
1.0 ST array platform. For proteomics, protein was prepared from one to three biological
replicates per cohort. For metabolite measurements, all individuals in all cohorts were
measured individually after polar extraction of samples.
SRM Assay Development and Protein Quantification
Generation of peptide library and development ofSRM assays were performed as described
(Picotti et al., 2010). Identical SRM assays for all 192 target proteins were run on all 77
cohorts. SRM traces were manually checked according to established criteria (Lange et al.,
2008a). For relative quantification of each protein across the set of different cohorts, the raw
intensity of transitions of the native and (13C6, 15N4)-Arginine, (13C6, 15N2)-Lysine peptides
were considered. The technical reproducibility of SRM-based quantification was validated
by measuring the individual samples with three independent mass spectrometry injections.
General Informatic Analyses
Outliers were Windsorized prior to all analyses. SNP analysis was also performed using
GeneNetwork, which contains the full sequence data of C57BL/6J and DBA/2J, as well as
high density genotype information for all the BXD lines. The correlations are Pearson’s r or
Spearman’s rho, depending on the absence or presence of outliers. Student’s t test was used
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for comparing two groups in normalized data (all protein and mRNA are normalized).
Bonferroni’s correction for multiple testing was performed, and cutoffs for both nominal
significance (p < 0.05) and corrected significance (p < 0.05/n tests) are displayed. Except for
QTL plots, graphs and analyses were performed in R.
Metabolite Measurements
Murine metabolite measurements for this study were performed on serum and livers from
the BXDs using ultra performance liquid chromatrography-mass spectrometry and flow-
injection time-of-flight mass spectrometry, respectively. Human urinalysis was performed
on 835 Caucasian adults in the CoLaus study, including 43 diabetics and 792 nondiabetics,
males and females. The CoLaus study was approved by the Institutional Ethics Committee
of the University of Lausanne. All study participants gave written consent. Full details of the
human NMR metabolomics data are in a separate parallel publication (Rueedi et al., 2014).
Data Repository
All BXD data can be found at http://www.GeneNetwork.org. To download the clinical
phenotype data, change the type to “Phenotypes” and enter “LISP2” to find all associated
results. Select all and export to recover the data, or analyze it online. Microarray data and
protein measurements can be found on the same resource; change the type to “Liver
Proteome” or “Liver mRNA” and navigate to the named EPFL data sets under CD or HFD
(e.g., EPFL/LISP BXD CD Liver Affy Mouse Gene 1.0 ST [Apr13] RMA). To download
these data, please click the “INFO” button at the right-hand side of the search page and
download the raw data set in the upper right box of the screen.
Extended Experimental Procedures and Supplemental References are available in the
Supplemental Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SRM-Based Protein Quantification and Covariation Network
(A) SRM assay development for targeted proteomic measurements; 309 peptides
corresponding to 192 genes were designed and synthesized via SPOT synthesis. Fragment
ion spectra were generated on a triple-quadrupole MS with the SRM-triggered MS2 mode,
and then ions were selected based on their relative intensities. Dot colors indicate different
amino acids. The following abbreviation was used: m/z, mass-to-charge ratio. Mouse liver
homogenate combined with the heavy reference proteome was analyzed with SRM on a
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triple-quadrupole MS. Different dot colors represent different peptides (Quadrupole 1) or
product ions (Quadrupole 3).
(B) Biological replicates had near-perfect reproducibility (r2 ~ 0.98), shown here for all
three biological replicates of the BXD60 CD cohort.
(C) Two-way cluster analysis of protein (top) and transcript (bottom) abundances in all 77
cohorts (40 CD, 37 HFD). Columns are clustered based on samples, and rows are clustered
based on gene-product abundances. Protein and transcript abundances are colored in a red-
blue scale. Red, high abundance; blue, low abundance; white, missing data.
(D) Protein association network based on robust Spearman correlation measures for all
protein pairs. Statistically significant and strong positive associations (p < 0.01 and r > 0.6)
are edges. The largest correlation clusters are labeled “a,” “b,” and “c.” Nodes are labeled
with protein names and colored according to their biological process, as reported by DAVID
(Huang et al., 2009).
Wu et al. Page 17













Figure 2. mRNA and Protein Overview
(A) Circos plot of mRNA and protein data for all 192 genes, labeled on outer edge. Genes
are represented by two bars: light for CD and dark for HFD. Genes are arranged by relative
chromosome position; the chromosome length is according to number of genes measured.
Blue bars indicate the transcript relative expression CD versus HFD; orange bars indicate
the protein relative expression CD versus HFD. Bars with more unequal heights indicate diet
has a larger impact. Green bars indicate the correlation between the transcript and protein for
each gene within each diet. Fuchsia bars represent the strength of the peak eQTL. Yellow
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bars represent the strength of the peak pQTL. The two bars are overlaid with transparency.
The dashed green line represents the simplified significance cutoff (LRS ≥ 18). The inner
ring indicates the chromosome location. The blue central lines represent significant eQTLs,
and the red central lines represent significant pQTLs. The central solid lines represent cis-
QTLs, and the central dashed lines represent trans-QTLs. QTL lines stem from the LRS bar
graph and terminate on the inner side of the chromosome ring at the approximate QTL
location.
(B) Magnified view of eQTLs and pQTLs mapping to chromosome 5.
(C) In CD ~25% (left), and in HFD ~30% (right), of transcripts correlate nominally
significantly with their protein. The lower strip charts show correlation distribution.
Spearman correlation values corresponding to nominal significance (p < 0.05) and corrected
significance (p < 0.0002) are displayed on the axis.
(D) Venn diagram of genes that are differentially regulated between CD and HFD as
transcripts (blue), proteins (red), both (purple), or neither (gray).
(E) Volcano plot for mRNA showing the magnitude of dietary effect versus significance.
~45% vary with nominal significance (p < 0.05) between the dietary conditions.
Approximately 19% vary with corrected significance (raw p < 0.0003). Some extreme genes
are labeled.
(F) Plot of the effect of diet on transcripts versus the effect of diet on proteins. In general,
transcripts and proteins are similarly affected by diet.
Related to Tables S1 and S2.
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Figure 3. QTL Overview
(A) Venn diagram separating all genes with distinct QTLs based on provenance.
(B) Venn diagrams separating eQTLs or pQTLs by dietary source and regulatory
mechanism. Overlapping regions indicates genes giving an eQTL or pQTL in both diets;
white numbers are counted twice for QTL count, but once for distinct gene count (e.g., there
are 48 significant cis-eQTLs, which stem from 28 distinct genes).
(C) In both diets, DHTKD1 and Dhtkd1 share a common cis-QTL, are unaffected by diet,
and strongly correlate.
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(D) NNT and Nnt display a similar pattern.
(E) Car3 has only one significant pQTL despite an absence of dietary effect and a strong
transcript-protein correlation.
(F) PMPCB does not map to a significant pQTL; however, Pmpcb maps to a significant cis-
eQTL in both diets, despite a strong transcriptional upregulation by HFD. The transcript and
protein levels do not correlate.
(G) Mup3 and MUP3 do not map to significant QTLs, despite having high levels of
variation and a strong transcript-protein correlation.
Related to Figure S1.
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Figure 4. Metabolic Consequences of BCKDHB and DHTKD1
(A) BCKDHB is the E1b subunit of the BCKD complex, which irreversibly converts several
BCKAs.
(B) Bckdhb mRNA has the strongest eQTLs of the 192 target genes examined in the liver
and has among the strongest pQTLs. Neither transcript nor protein is affected by diet.
(C) The BCAA/alanine ratio is significantly increased in animals with the dysfunctional
C57BL/6 allele in CD serum and liver measurements and HFD liver measurements, in line
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with it acting as a risk for MSUD. Red line represents median of strains with the C57BL/6
allele, and purple lines represent the median of strains with the DBA/2 allele.
(D) DHTKD1 is the E1 subunit of the dehydrogenase complex that catalyzes the irreversible
conversion of 2-oxoadipate to glutaryl-CoA.
(E) Left: serum 2-AA levels are strongly related to DHTKD1, as are liver levels (not
shown). Right: other upstream metabolites in the DHTKD1 pathway correlate strongly with
one another, e.g., 2-AA and 2-AA semialdehyde, shown here in liver.
(F) Serum 2-AA maps as an mQTL in both diets to proximal chromosome 2, the location of
DHTKD1.
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Figure 5. Physiological Consequences of DHTKD1 Variants
(A) Liver size, serum cholesterol, and fasted glucose levels increase after HFD across the
BXDs. Error bars represent mean + SEM.
(B) In CD livers, 2-AA is associated negatively with liver mass, serum cholesterol, insulin,
and glucose. In HFD livers, 2-AA is associated negatively with liver mass and fasting
glucose.
(C) Liver levels of saccharopine, a metabolite upstream of 2-AA, are also associated
negatively with the same phenotypes, although only in CD.
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(D) 2-AA levels in the liver are significantly decreased in HFD-fed BXD cohorts.
(E) However, when correcting for diabetes status (HOMA-IR > 10 as diabetic, or HOMA-IR
< 5 as healthy), there was no difference between CD and HFD—instead, only between
diabetic and nondiabetic cohorts.
(F) Using publicly available data from a recent metabolomic profiling of livers from the
HMDP (Ghazalpour et al., 2014), we can observe that the inverse relationship between 2-
AA and fasted glucose is highly consistent in mouse populations. p = 0.01 if the four high
nonoutliers in the low group are suppressed.
(G) Also in a human population study with urine metabolomics, diabetic patients had
markedly lower levels of 2-AA.
Related to Figure S2.
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Figure 6. The Mitochondrial Unfolded Protein Response
(A) UPRmt induction in C. elegans triggered by interference with ETC (RNAi of cco-1) or
mitochondrial proteostasis (RNAi for spg-7). These triggers result in upregulation of UPRmt
effectors hsp-6, clpp-1, and lonp-1 and a reduction in ubl-5. The orthologous mouse genes
are indicated below the respective C. elegans gene symbol. Error bars represent mean +
SEM.
(B) UPRmt induction in C. elegans decreases movement, size, and oxygen consumption.
(C) UPRmt genes and proteins form a network of coordinately expressed mRNAs and
proteins in vivo in mice, which is stronger at the protein than at the mRNA level.
(D) Cox5b and Spg7 (orthologs of C. elegans cco-1 and spg-7) are generally negatively
associated with the levels of all UPRmt genes in CD cohorts, particularly at the protein level,
in line with observations in the worm.
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(E) While the levels of Cox5b and Spg7 are not affected by diet, expression is consistent by
strain across the two diets only for Cox5b.
(F) The UPRmt network in HFD livers is similar to that observed in CD, but somewhat
weaker. Ubl5 remains a striking negative correlate at the mRNA level.
(G) In HFD, Cox5b remains a negative correlate of UPRmt transcripts and proteins, while
Spg7 does not.
(H) The features of the UPRmt network are also conserved in 427 human liver biopsies
(Schadt et al., 2008), 405 lung biopsies (Ding et al., 2004), 180 lymphoblast lines (Monks et
al., 2004), and 43 hippocampi (Berchtold et al., 2008).
(I) In humans, SPG7 is a consistent negative correlate of the UPRmt transcripts.
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